Click for best price
Children Respiratory Syncytial Virus Therapeutics Market Size, Share 2024
This research report provides a comprehensive analysis of the Children Respiratory Syncytial Virus Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Children Respiratory Syncytial Virus Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Children Respiratory Syncytial Virus Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Children Respiratory Syncytial Virus Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Children Respiratory Syncytial Virus Therapeutics market presents opportunities for various stakeholders, including Drug Stores and Retail Pharmacies, Hospital Pharmacies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Children Respiratory Syncytial Virus Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Children Respiratory Syncytial Virus Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Children Respiratory Syncytial Virus Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Children Respiratory Syncytial Virus Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Children Respiratory Syncytial Virus Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral, lnjectable), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Children Respiratory Syncytial Virus Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Children Respiratory Syncytial Virus Therapeutics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Children Respiratory Syncytial Virus Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Children Respiratory Syncytial Virus Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Children Respiratory Syncytial Virus Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Children Respiratory Syncytial Virus Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Children Respiratory Syncytial Virus Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Children Respiratory Syncytial Virus Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Children Respiratory Syncytial Virus Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Oral
lnjectable
Others
Market segment by Application
Drug Stores and Retail Pharmacies
Hospital Pharmacies
Others
Global Children Respiratory Syncytial Virus Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
F.Hoffmann-La Roche Ltd.
AstraZeneca plc
Merck & Co.,Inc.
AbbVie, Inc.
Valeant Pharmaceuticals International, Inc.
GlaxoSmithKline plc
ReViral Ltd.
Gilead Sciences, Inc.
Medivir AB
Teva Pharmaceuticals Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Children Respiratory Syncytial Virus Therapeutics, market overview.
Chapter 2: Global Children Respiratory Syncytial Virus Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Children Respiratory Syncytial Virus Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Children Respiratory Syncytial Virus Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Children Respiratory Syncytial Virus Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Children Respiratory Syncytial Virus Therapeutics Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
122 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Children Respiratory Syncytial Virus Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Children Respiratory Syncytial Virus Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Children Respiratory Syncytial Virus Therapeutics Overall Market Size
2.1 Global Children Respiratory Syncytial Virus Therapeutics Market Size: 2023 VS 2030
2.2 Global Children Respiratory Syncytial Virus Therapeutics Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Children Respiratory Syncytial Virus Therapeutics Sales: 2019-2030
3 Company Landscape
3.1 Top Children Respiratory Syncytial Virus Therapeutics Players in Global Market
3.2 Top Global Children Respiratory Syncytial Virus Therapeutics Companies Ranked by Revenue
3.3 Global Children Respiratory Syncytial Virus Therapeutics Revenue by Companies
3.4 Global Children Respiratory Syncytial Virus Therapeutics Sales by Companies
3.5 Global Children Respiratory Syncytial Virus Therapeutics Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Children Respiratory Syncytial Virus Therapeutics Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Children Respiratory Syncytial Virus Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Children Respiratory Syncytial Virus Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Children Respiratory Syncytial Virus Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Children Respiratory Syncytial Virus Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Children Respiratory Syncytial Virus Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 lnjectable
4.1.4 Others
4.2 By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
4.3 By Type - Global Children Respiratory Syncytial Virus Therapeutics Sales & Forecasts
4.3.1 By Type - Global Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2024
4.3.2 By Type - Global Children Respiratory Syncytial Virus Therapeutics Sales, 2025-2030
4.3.3 By Type - Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
4.4 By Type - Global Children Respiratory Syncytial Virus Therapeutics Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Children Respiratory Syncytial Virus Therapeutics Market Size, 2023 & 2030
5.1.2 Drug Stores and Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Others
5.2 By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
5.3 By Application - Global Children Respiratory Syncytial Virus Therapeutics Sales & Forecasts
5.3.1 By Application - Global Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2024
5.3.2 By Application - Global Children Respiratory Syncytial Virus Therapeutics Sales, 2025-2030
5.3.3 By Application - Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
5.4 By Application - Global Children Respiratory Syncytial Virus Therapeutics Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Children Respiratory Syncytial Virus Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
6.3 By Region - Global Children Respiratory Syncytial Virus Therapeutics Sales & Forecasts
6.3.1 By Region - Global Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2024
6.3.2 By Region - Global Children Respiratory Syncytial Virus Therapeutics Sales, 2025-2030
6.3.3 By Region - Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2030
6.4.2 By Country - North America Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2030
6.4.3 US Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.4.4 Canada Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.4.5 Mexico Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2030
6.5.2 By Country - Europe Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2030
6.5.3 Germany Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.5.4 France Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.5.5 U.K. Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.5.6 Italy Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.5.7 Russia Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.5.8 Nordic Countries Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.5.9 Benelux Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2030
6.6.2 By Region - Asia Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2030
6.6.3 China Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.6.4 Japan Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.6.5 South Korea Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.6.6 Southeast Asia Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.6.7 India Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2030
6.7.2 By Country - South America Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2030
6.7.3 Brazil Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.7.4 Argentina Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Sales, 2019-2030
6.8.3 Turkey Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.8.4 Israel Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.8.5 Saudi Arabia Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
6.8.6 UAE Children Respiratory Syncytial Virus Therapeutics Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 F.Hoffmann-La Roche Ltd.
7.1.1 F.Hoffmann-La Roche Ltd. Company Summary
7.1.2 F.Hoffmann-La Roche Ltd. Business Overview
7.1.3 F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.1.4 F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.1.5 F.Hoffmann-La Roche Ltd. Key News & Latest Developments
7.2 AstraZeneca plc
7.2.1 AstraZeneca plc Company Summary
7.2.2 AstraZeneca plc Business Overview
7.2.3 AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.2.4 AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.2.5 AstraZeneca plc Key News & Latest Developments
7.3 Merck & Co.,Inc.
7.3.1 Merck & Co.,Inc. Company Summary
7.3.2 Merck & Co.,Inc. Business Overview
7.3.3 Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.3.4 Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.3.5 Merck & Co.,Inc. Key News & Latest Developments
7.4 AbbVie, Inc.
7.4.1 AbbVie, Inc. Company Summary
7.4.2 AbbVie, Inc. Business Overview
7.4.3 AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.4.4 AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.4.5 AbbVie, Inc. Key News & Latest Developments
7.5 Valeant Pharmaceuticals International, Inc.
7.5.1 Valeant Pharmaceuticals International, Inc. Company Summary
7.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
7.5.3 Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.5.4 Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.5.5 Valeant Pharmaceuticals International, Inc. Key News & Latest Developments
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Company Summary
7.6.2 GlaxoSmithKline plc Business Overview
7.6.3 GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.6.4 GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.6.5 GlaxoSmithKline plc Key News & Latest Developments
7.7 ReViral Ltd.
7.7.1 ReViral Ltd. Company Summary
7.7.2 ReViral Ltd. Business Overview
7.7.3 ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.7.4 ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.7.5 ReViral Ltd. Key News & Latest Developments
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Company Summary
7.8.2 Gilead Sciences, Inc. Business Overview
7.8.3 Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.8.4 Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.8.5 Gilead Sciences, Inc. Key News & Latest Developments
7.9 Medivir AB
7.9.1 Medivir AB Company Summary
7.9.2 Medivir AB Business Overview
7.9.3 Medivir AB Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.9.4 Medivir AB Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.9.5 Medivir AB Key News & Latest Developments
7.10 Teva Pharmaceuticals Industries Ltd.
7.10.1 Teva Pharmaceuticals Industries Ltd. Company Summary
7.10.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.10.3 Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Major Product Offerings
7.10.4 Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Sales and Revenue in Global (2019-2024)
7.10.5 Teva Pharmaceuticals Industries Ltd. Key News & Latest Developments
8 Global Children Respiratory Syncytial Virus Therapeutics Production Capacity, Analysis
8.1 Global Children Respiratory Syncytial Virus Therapeutics Production Capacity, 2019-2030
8.2 Children Respiratory Syncytial Virus Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Children Respiratory Syncytial Virus Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Children Respiratory Syncytial Virus Therapeutics Supply Chain Analysis
10.1 Children Respiratory Syncytial Virus Therapeutics Industry Value Chain
10.2 Children Respiratory Syncytial Virus Therapeutics Upstream Market
10.3 Children Respiratory Syncytial Virus Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Children Respiratory Syncytial Virus Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Children Respiratory Syncytial Virus Therapeutics in Global Market
Table 2. Top Children Respiratory Syncytial Virus Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Children Respiratory Syncytial Virus Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Children Respiratory Syncytial Virus Therapeutics Revenue Share by Companies, 2019-2024
Table 5. Global Children Respiratory Syncytial Virus Therapeutics Sales by Companies, (K Units), 2019-2024
Table 6. Global Children Respiratory Syncytial Virus Therapeutics Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Children Respiratory Syncytial Virus Therapeutics Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Children Respiratory Syncytial Virus Therapeutics Product Type
Table 9. List of Global Tier 1 Children Respiratory Syncytial Virus Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Children Respiratory Syncytial Virus Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units), 2019-2024
Table 15. By Type - Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units), 2025-2030
Table 16. By Application ? Global Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units), 2019-2024
Table 20. By Application - Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units), 2025-2030
Table 21. By Region ? Global Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units), 2019-2024
Table 25. By Region - Global Children Respiratory Syncytial Virus Therapeutics Sales (K Units), 2025-2030
Table 26. By Country - North America Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2019-2024
Table 29. By Country - North America Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2025-2030
Table 30. By Country - Europe Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2019-2024
Table 33. By Country - Europe Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2025-2030
Table 34. By Region - Asia Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2019-2024
Table 37. By Region - Asia Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2025-2030
Table 38. By Country - South America Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2019-2024
Table 41. By Country - South America Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Sales, (K Units), 2025-2030
Table 46. F.Hoffmann-La Roche Ltd. Company Summary
Table 47. F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 48. F.Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. F.Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 50. AstraZeneca plc Company Summary
Table 51. AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 52. AstraZeneca plc Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. AstraZeneca plc Key News & Latest Developments
Table 54. Merck & Co.,Inc. Company Summary
Table 55. Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 56. Merck & Co.,Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Merck & Co.,Inc. Key News & Latest Developments
Table 58. AbbVie, Inc. Company Summary
Table 59. AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 60. AbbVie, Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. AbbVie, Inc. Key News & Latest Developments
Table 62. Valeant Pharmaceuticals International, Inc. Company Summary
Table 63. Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 64. Valeant Pharmaceuticals International, Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Valeant Pharmaceuticals International, Inc. Key News & Latest Developments
Table 66. GlaxoSmithKline plc Company Summary
Table 67. GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 68. GlaxoSmithKline plc Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. GlaxoSmithKline plc Key News & Latest Developments
Table 70. ReViral Ltd. Company Summary
Table 71. ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 72. ReViral Ltd. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. ReViral Ltd. Key News & Latest Developments
Table 74. Gilead Sciences, Inc. Company Summary
Table 75. Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 76. Gilead Sciences, Inc. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Gilead Sciences, Inc. Key News & Latest Developments
Table 78. Medivir AB Company Summary
Table 79. Medivir AB Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 80. Medivir AB Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Medivir AB Key News & Latest Developments
Table 82. Teva Pharmaceuticals Industries Ltd. Company Summary
Table 83. Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Product Offerings
Table 84. Teva Pharmaceuticals Industries Ltd. Children Respiratory Syncytial Virus Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Teva Pharmaceuticals Industries Ltd. Key News & Latest Developments
Table 86. Children Respiratory Syncytial Virus Therapeutics Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global Children Respiratory Syncytial Virus Therapeutics Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Children Respiratory Syncytial Virus Therapeutics Production by Region, 2019-2024 (K Units)
Table 89. Global Children Respiratory Syncytial Virus Therapeutics Production by Region, 2025-2030 (K Units)
Table 90. Children Respiratory Syncytial Virus Therapeutics Market Opportunities & Trends in Global Market
Table 91. Children Respiratory Syncytial Virus Therapeutics Market Drivers in Global Market
Table 92. Children Respiratory Syncytial Virus Therapeutics Market Restraints in Global Market
Table 93. Children Respiratory Syncytial Virus Therapeutics Raw Materials
Table 94. Children Respiratory Syncytial Virus Therapeutics Raw Materials Suppliers in Global Market
Table 95. Typical Children Respiratory Syncytial Virus Therapeutics Downstream
Table 96. Children Respiratory Syncytial Virus Therapeutics Downstream Clients in Global Market
Table 97. Children Respiratory Syncytial Virus Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Children Respiratory Syncytial Virus Therapeutics Segment by Type in 2023
Figure 2. Children Respiratory Syncytial Virus Therapeutics Segment by Application in 2023
Figure 3. Global Children Respiratory Syncytial Virus Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Children Respiratory Syncytial Virus Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Children Respiratory Syncytial Virus Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. Children Respiratory Syncytial Virus Therapeutics Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Children Respiratory Syncytial Virus Therapeutics Revenue in 2023
Figure 9. By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 11. By Type - Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 12. By Type - Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Application - Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 16. By Application - Global Children Respiratory Syncytial Virus Therapeutics Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 20. By Region - Global Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 21. By Country - North America Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 22. By Country - North America Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 23. US Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 28. Germany Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. France Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 37. China Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. India Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 43. By Country - South America Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 44. Brazil Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Children Respiratory Syncytial Virus Therapeutics Sales Market Share, 2019-2030
Figure 48. Turkey Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Children Respiratory Syncytial Virus Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 52. Global Children Respiratory Syncytial Virus Therapeutics Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Children Respiratory Syncytial Virus Therapeutics by Region, 2023 VS 2030
Figure 54. Children Respiratory Syncytial Virus Therapeutics Industry Value Chain
Figure 55. Marketing Channels
